Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease.
Ma L, Koehn B, Zaiken M, Hippen KL, Smith K, Allred J, Williams R, Yao K, Fink J, Saha A, Koop B, Payne N, Widelak R, Panoskaltsis-Mortari A, Riddle MJ, Tolar J, Eide C, Xia L, Witty AD, Mehta AK, Denholtz M, Hefazi M, Hani S, Kenderian SS, Miller JS, Molldrem JJ, Kean LS, Valamehr B, Blazar BR.
Ma L, et al. Among authors: witty ad.
Blood. 2025 Oct 23;146(17):2047-2062. doi: 10.1182/blood.2025028562.
Blood. 2025.
PMID: 40700578